NCT01837693View on ClinicalTrials.gov

Cervical Cancer Prevention: From DNA to mRNA? - New Technologies for Cervical Cancer Screening 2

NACompletedINTERVENTIONAL

Enrollment

41,127

Participants

Timeline

Start Date

June 1, 2013

Primary Completion Date

January 1, 2017

Study Completion Date

January 1, 2017

Conditions

Precancerous ConditionsNeoplasms

Interventions

PROCEDURE

Experimental: immediate colposcopy

A immediate colposcopy in this arm may detect potentially spontaneous regressive cervical lesions, so may determine an over diagnosis and over treatment, which the study want to estimate

Trial Locations (5)

Unknown

Unità Locale Socio-Sanitaria 17 Este Monselice, Este

Istituto per lo Studio e la Prevenzione Oncologica, Florence

Azienda Sanitaria Locale 2- Regione Umbria, Perugia

Azienda Sanitaria della Provincia Autonoma di Trento, Trento

Centro per la Prevenzione Oncologica del Piemonte, Turin

All Listed Sponsors

lead

Azienda USL Reggio Emilia - IRCCS

OTHER_GOV

NCT01837693 - Cervical Cancer Prevention: From DNA to mRNA? - New Technologies for Cervical Cancer Screening 2 | Biotech Hunter | Biotech Hunter